Stock Market News1 month NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines Zacks
Novavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone flu vaccines.
XNovavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone flu vaccines.
X